Name Net new
positions
New positions Closed positions Return since
31 Mar ‘15
26
29 29 0 8.77%
27
28 43 15 49.9%
28
28 40 12 66.6%
ABUS icon
29
Arbutus Biopharma
ABUS
$865M
28 46 18 74.2%
30
28 31 3 60.5%
31
28 31 3 108%
32
27 46 19 16.9%
33
27 30 3 50.7%
34
27 30 3 229%
35
27 37 10 39.1%
CRI icon
36
Carter's
CRI
$1.11B
26 51 25 67%
37
26 39 13 84.8%
38
25 53 28 78.6%
39
25 40 15 48.5%
40
25 36 11 185%
41
25 34 9 3.96%
42
24 37 13 73.8%
43
24 37 13 22.1%
44
24 24 0 53.1%
45
23 49 26 81.6%
46
23 32 9 75.6%
47
23 37 14 41.1%
48
23 31 8 87.9%
49
22 31 9 76.6%
50
22 40 18 66.1%